[Insulin-resistance and cardiovascular risk]
Alessandra Dei Cas1, Valentina Spigoni, Marco Metra
1Dipartimento di Medicina Interna e Scienze Biomediche, Università degli Studi, Parma. alessandra.deicas@unipr.it
Giornale Italiano Di Cardiologia (2006)
|March 23, 2011
Summary
Insulin resistance, a condition linked to metabolic and hemodynamic issues, significantly raises cardiovascular risks. Understanding its mechanisms and consequences is crucial for managing metabolic syndrome and preventing heart disease.
Area of Science:
- Endocrinology
- Metabolic Medicine
- Cardiovascular Science
Background:
- Insulin resistance is a key factor in metabolic dysfunction.
- It is linked to a range of abnormalities affecting metabolism and hemodynamics.
- These abnormalities contribute to increased cardiovascular morbidity and mortality.
Purpose of the Study:
- To summarize the primary pathophysiological mechanisms of insulin resistance.
- To outline the metabolic consequences associated with insulin resistance.
- To discuss the link between insulin resistance and cardiovascular disease, and the utility of metabolic syndrome as a diagnostic concept.
Main Methods:
- This study is a review of existing literature.
- It synthesizes information on the pathophysiology and metabolic effects of insulin resistance.
- It examines the relationship between insulin resistance and cardiovascular disease.
Main Results:
- Insulin resistance involves complex pathophysiological mechanisms.
- It leads to significant metabolic disturbances.
- A strong correlation exists between insulin resistance and cardiovascular disease.
Conclusions:
- Insulin resistance is a central component of metabolic syndrome.
- Recognizing insulin resistance is vital for cardiovascular risk assessment.
- The concept of metabolic syndrome offers practical diagnostic utility.
More Related Videos
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...